Miriam Teoli

Pharmacogenetics of psoriasis:<i>HLA-Cw6</i>but not<i>LCE3B/3C</i>deletion nor<i>TNFAIP3</i>polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab

Marina Talamonti, E. Botti, Marco Galluzzo et al. · British Journal of Dermatology · 2013 · 143 citations

A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors

Maria Sole Chimenti, Paola Triggianese, Paola Conigliaro et al. · Clinical Rheumatology · 2017 · 41 citations

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +11

Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study

Maria Sole Chimenti, Augusta Ortolan, Mariagrazia Lorenzin et al. · Clinical Rheumatology · 2018 · 40 citations

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +10

Role of Contrast-Enhanced Ultrasound in Early Diagnosis of Psoriatic Arthritis

F. M. Solivetti, Fulvia Elia, Miriam Teoli et al. · Dermatology · 2009 · 32 citations

Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject

Rosita Saraceno, Miriam Teoli, Sergio Chimenti · Clinical Therapeutics · 2008 · 30 citations

Tumor Biology, Medicine, Surgical Pathology +9